Anna Fyrberg Selected Research

deoxyguanosine kinase

1/2015	Nucleoside Analog Activity in Malignant Melanoma Cell Lines.
3/2006	The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Fyrberg Research Topics

Disease

1	Hematologic Neoplasms (Hematological Malignancy) 01/2015
1	Melanoma (Melanoma, Malignant) 01/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2011
1	Adenocarcinoma of Lung 09/2011
1	Inflammation (Inflammations) 04/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2006

Drug/Important Bio-Agent (IBA)

2	deoxyguanosine kinaseIBA 01/2015 - 03/2006
2	NucleosidesIBA 01/2015 - 09/2011
1	Small Interfering RNA (siRNA)IBA 01/2015
1	nasIBA 01/2015
1	EnzymesIBA 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 09/2011
1	Hemoglobins (Hemoglobin)IBA 09/2011
1	LipopolysaccharidesIBA 04/2008
1	ProdrugsIBA 03/2006
1	Messenger RNA (mRNA)IBA 03/2006
1	Cladribine FDA LinkGeneric 03/2006
1	Deoxycytidine KinaseIBA 03/2006
1	DeoxycytidineIBA 03/2006
1	fludarabineIBA 03/2006